Pancreatic Cancer Research

ResearcherRuhr University BochumNo recent work listed

Johanna B. Munding

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9699-8271; OpenAlex author ID A5023753562. Sources: OpenAlex.

Their work

Papers
13
Trials
0
Grants
0
Labs led
0
Collaborators
29
Papers, trials and grants by year

2011: 1 paper · 2012: 3 papers · 2013: none · 2014: 2 papers · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: 2 papers · 2020: 1 paper · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper

Papers 13

  1. The impact of resection margin distance on survival and recurrence in pancreatic ductal adenocarcinoma in a retrospective cohort analysis. Co-author DOI 10.1371/journal.pone.0281921↗
  2. [Pathological processing in pancreatic ductal adenocarcinoma-What is new?] Co-author DOI 10.1007/s00104-022-01615-w↗
  3. Recurrence of Pancreatic Ductal Adenocarcinoma after Complete Histopathological Remission Caused by FOLFIRINOX. Co-author DOI 10.1159/000509231↗
  4. Prognostic value and impact of cerebral metastases in pancreatic cancer. Co-author DOI 10.1080/00015458.2018.1549379↗
  5. Surprising Twist in the Plot - Sister Mary Joseph's Nodule of Pancreatic Cancer Mimicking Wound Infection after Umbilical Hernia Repair. Co-author DOI 10.1007/s12029-017-9975-0↗
  6. Pathologic Complete Response of Pancreatic Cancer following Neoadjuvant FOLFIRINOX Treatment in Hepatic Metastasized Pancreatic Cancer. Co-author DOI 10.1159/000497827↗
  7. FOLFIRINOX treatment leading to pathologic complete response of a locally advanced pancreatic cancer. Co-author DOI 10.21037/jgo.2018.01.07↗
  8. [Update of the S3 guidelines for pancreatic cancer. What is new for pathologists?]. Co-author DOI 10.1007/s00292-012-1712-7↗
  9. A microRNA-based test improves endoscopic ultrasound-guided cytologic diagnosis of pancreatic cancer. Co-author DOI 10.1016/j.cgh.2014.02.038↗
  10. Global microRNA expression profiling of microdissected tissues identifies miR-135b as a novel biomarker for pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/ijc.26466↗
  11. Lack of CCR7 expression is rate limiting for lymphatic spread of pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/ijc.26502↗
  12. Rare solid tumors of the pancreas as differential diagnosis of pancreatic adenocarcinoma. Co-author DOI 10.6092/1590-8577/791↗
  13. [R classification and pancreatic ductal adenocarcinoma--R 0 is R 0]. Co-author DOI 10.1055/s-0031-1281750↗

Closest collaborators

The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Andrea Tannapfel · 7 shared papers, 2011–2023 · strength 0.76
  2. Waldemar H. Uhl · 8 shared papers, 2011–2021 · strength 0.70
  3. Andreas Minh Luu · 5 shared papers, 2018–2021 · strength 0.60
  4. Chris Braumann · 5 shared papers, 2018–2021 · strength 0.60
  5. Philipp Höhn · 4 shared papers, 2018–2021 · strength 0.48
  6. Dirk Weyhe · 1 shared paper, 2023 · strength 0.24
  7. Dennis Obonyo · 1 shared paper, 2023 · strength 0.24
  8. Anke Reinacher‐Schick · 2 shared papers, 2018–2019 · strength 0.20
  9. Stephan A. Hahn · 3 shared papers, 2012–2014 · strength 0.09
  10. Iréne Esposito · 1 shared paper, 2014 · strength 0.06
  11. Anna E. Szafranska-Schwarzbach · 2 shared papers, 2012–2014 · strength 0.06
  12. Sabine Kersting · 1 shared paper, 2012 · strength 0.03
  13. Uwe Bergmann · 1 shared paper, 2012 · strength 0.03
  14. Bernard F. Andruss · 1 shared paper, 2014 · strength 0.03
  15. Gregory J. Tsongalis · 1 shared paper, 2014 · strength 0.03
  16. Stuart R. Gordon · 1 shared paper, 2014 · strength 0.03
  17. Darwin Lewis Conwell · 1 shared paper, 2014 · strength 0.03
  18. Anna Wiechowska–Kozłowska · 1 shared paper, 2014 · strength 0.03
  19. Timothy B. Gardner · 1 shared paper, 2014 · strength 0.03
  20. Arief Antonius Suriawinata · 1 shared paper, 2014 · strength 0.03
  21. Barbara Ann Centeno · 1 shared paper, 2014 · strength 0.03
  22. Randall E. Brand · 1 shared paper, 2014 · strength 0.03
  23. David Clement Whitcomb · 1 shared paper, 2014 · strength 0.03
  24. Jan Sperveslage · 1 shared paper, 2012 · strength 0.03
  25. Nathalia A. Giese · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.